AbbVie Soothes Safety Fears With More Upadacitinib RA Data

 
• By Kevin Grogan
Safety
Regulators may tread carefully when reviewing AbbVie's upadacitinib • Source: Shutterstock

More from Immunological

More from Therapeutic Category